Skip to main content
Clinical Trials/CTRI/2025/08/092831
CTRI/2025/08/092831Not yet recruitingNot Applicable

InVivo Confocal microscopy on Infectious Scleritis

L V Prasad Eye Institute1 site in 1 country30 target enrollmentStarted: August 25, 2025Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
30
Locations
1
Primary Endpoint
Able to diagnose infective organism in patients of infectious scleritis

Study Overview

Brief Summary

A topical anesthetic (Paracain) will be applied to ensure comfort. After explaining the procedure, subjects will be positioned at the chinrest and instructed to fixate on a light source. IVCM will then be used to image the sclera in all four quadrants in Both eyes, focusing on clinically affected areas. Images will be stored for subsequent analysis.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 90.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •1.All age groups with adequate cooperation 2.Clinically diagnosed cases of scleritis with suspected infectious aetiology.

Exclusion Criteria

  • •1.Excessive ocular discharge 2.Severe conjunctival chemosis 3.Corneal perforation or extreme corneal and scleral thinning 4.Significant eyelid abnormality that interferes with imaging (e.g., severe entropion, ectropion, blepharospasm) 5.History of tarsorrhaphy (partial or complete), unless lid separation is possible and scleral area is accessible for imaging.
  • •6.Known allergy to topical anaesthetic drops.

Outcomes

Primary Outcomes

Able to diagnose infective organism in patients of infectious scleritis

Time Frame: 1 week , 1 month

Secondary Outcomes

  • Compare with microbiology(1 day and 1 month)

Investigators

Sponsor Class
Other [Non Profitable Organization]
Responsible Party
Principal Investigator
Principal Investigator

DrBhupesh Bagga

L V Prasad Eye Institute

Study Sites (1)

Loading locations...

Similar Trials